Friday, 12 April 2019

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)